Turtle CJ - Search Results

1

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL.

Liang EC, Albittar A, Huang JJ, Hirayama AV, Kimble EL, Portuguese AJ, Chapuis A, Shadman M, Till BG, Cassaday RD, Milano F, Kiem HP, Riddell SR, Turtle CJ, Maloney DG, Gauthier J. Liang EC, et al. Among authors: turtle cj. Blood Adv. 2023 Nov 28;7(22):6990-7005. doi: 10.1182/bloodadvances.2023011399. Blood Adv. 2023. PMID: 37774014 Free PMC article. Clinical Trial.

2

Dendritic cells in tumor immunology and immunotherapy.

Turtle CJ, Hart DN. Turtle CJ, et al. Curr Drug Targets. 2004 Jan;5(1):17-39. doi: 10.2174/1389450043490640. Curr Drug Targets. 2004. PMID: 14738216 Review.

3

The immune response to breast cancer, and the case for DC immunotherapy.

Allan CP, Turtle CJ, Mainwaring PN, Pyke C, Hart DN. Allan CP, et al. Among authors: turtle cj. Cytotherapy. 2004;6(2):154-63. doi: 10.1080/14653240410005249. Cytotherapy. 2004. PMID: 15203992 Review.

4

Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern.

Pérez O, Bracho G, Lastre M, Mora N, del Campo J, Gil D, Zayas C, Acevedo R, González D, López JA, Taboada C, Turtle C, Solis RL. Pérez O, et al. Immunol Cell Biol. 2004 Dec;82(6):603-10. doi: 10.1111/j.1440-1711.2004.01293.x. Immunol Cell Biol. 2004. PMID: 15550118

5

Chimeric antigen receptor modified T cell therapy for B cell malignancies.

Turtle CJ. Turtle CJ. Int J Hematol. 2014 Feb;99(2):132-40. doi: 10.1007/s12185-013-1490-x. Epub 2013 Dec 14. Int J Hematol. 2014. PMID: 24338745 Review.

6

DC in multiple myeloma immunotherapy.

Turtle CJ, Brown RD, Joshua DE, Hart DN. Turtle CJ, et al. Cytotherapy. 2004;6(2):128-37. doi: 10.1080/14653240410005357. Cytotherapy. 2004. PMID: 15203989 Review.

7

CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.

Radford KJ, Turtle CJ, Kassianos AJ, Hart DN. Radford KJ, et al. Among authors: turtle cj. J Immunother. 2006 Nov-Dec;29(6):596-605. doi: 10.1097/01.cji.0000211310.90621.5d. J Immunother. 2006. PMID: 17063122

8

Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy.

Radford KJ, Turtle CJ, Kassianos AJ, Vuckovic S, Gardiner D, Khalil D, Taylor K, Wright S, Gill D, Hart DN. Radford KJ, et al. Among authors: turtle cj. J Immunother. 2005 Jul-Aug;28(4):322-31. doi: 10.1097/01.cji.0000163592.66910.e4. J Immunother. 2005. PMID: 16000950

9

Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma.

Vari F, Munster DJ, Hsu JL, Rossetti TR, Mahler SM, Gray PP, Turtle CJ, Prue RL, Hart DN. Vari F, et al. Among authors: turtle cj. Br J Haematol. 2008 Nov;143(3):374-7. doi: 10.1111/j.1365-2141.2008.07346.x. Epub 2008 Aug 20. Br J Haematol. 2008. PMID: 18729856 Free article.

10

Q-fever associated with splenic infarction and an anti-cardiolipin antibody.

Turtle CJ, Coyle LA, Kotsiou G. Turtle CJ, et al. Aust N Z J Med. 1999 Oct;29(5):755-6. doi: 10.1111/j.1445-5994.1999.tb01635.x. Aust N Z J Med. 1999. PMID: 10630667 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page